This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 1991-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oakland, CA (US) (1991)
- Kirkland, WA (US) (1995)
Company Filing History:
Years Active: 1991-1995
Title: Kurt A Muetterties: Innovator in Magnetic Resonance Imaging
Introduction
Kurt A Muetterties is a notable inventor based in Oakland, CA (US). He has made significant contributions to the field of medical imaging, particularly through his innovative work on contrast agents for magnetic resonance imaging (MRI). With a total of 2 patents, his inventions have the potential to enhance diagnostic capabilities in medical practice.
Latest Patents
One of his latest patents focuses on contrast agents for magnetic resonance imaging of the small intestine. This method utilizes novel contrast agents that provide increased diagnostic information in MRI images of the hepatobiliary system and alimentary tract, especially the small intestine. The contrast agents developed are N-carboxylated desferrioxamine B complexes with metal ions, which represent a significant advancement in the field.
Career Highlights
Kurt A Muetterties has dedicated his career to advancing medical imaging technologies. His work at the University of California has positioned him as a key figure in the development of innovative imaging techniques. His contributions have not only improved diagnostic accuracy but have also paved the way for further research in the field.
Collaborations
Throughout his career, Kurt has collaborated with esteemed colleagues such as Barry L Engelstad and David L White. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kurt A Muetterties is a distinguished inventor whose work in magnetic resonance imaging has the potential to transform diagnostic practices. His innovative approach to developing contrast agents highlights the importance of research and collaboration in advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
